Vice President Clinical Pharmacology and Pharmacometrics @ (January 2024 - June 2025)
Senior Director, Head of Clinical Pharmacology and Pharmacometrics @ (September 2021 - January 2024)
Director, Clinical Pharmacology and Pharmacometrics @ (January 2020 - September 2021)
Principal Research Scientist, Global PK and PD and Pharmacometrics, @ Eli Lilly and Company (January 2015 - January 2020)
Associate Director, Global Clinical Pharmacology @ ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company (October 2011 - December 2014)
Sr Research Investigator, Clinical Pharmacology @ (October 2006 - October 2011)
Ling Gao Education
Vanderbilt University
Ph.D. (Pharmacology)
2002-2006
Ling Gao Skills
Biomarkers
Biotechnology
CRO
CTMS
Cell Biology
Clinical Development
Clinical Pharmacology
Clinical Research
Clinical Trials
Drug Development
Drug Discovery
Drug Metabolism
FDA
IND
Immunology
In Vitro
In Vivo
Oncology
Pharmaceutical Industry
Pharmacodynamics
Pharmacokinetics
Pharmacology
Regulatory Submissions
Translational Medicine
Ling Gao Summary
Ling Gao, based in Princeton, NJ, US, is currently a Vice President, Clinical Pharmacology at Bicara Therapeutics. Ling Gao brings experience from previous roles at Dragonfly Therapeutics, Inc., Taiho Oncology, Inc., Bristol-Myers Squibb and Eli Lilly and Company. Ling Gao holds a 2002 - 2006 Ph.D. in Pharmacology @ Vanderbilt University. With a robust skill set that includes Biomarkers, Biotechnology, CRO, CTMS, Cell Biology and more. Ling Gao has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Ling Gao?
Find contact details for 700 million professionals.